Cargando…
Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases
OBJECTIVE: To study the effect of methotrexate (MTX) and its discontinuation on the humoral immune response after COVID-19 vaccination in patients with autoimmune rheumatic diseases (AIRD). METHODS: In this retrospective study, neutralising SARS-CoV-2 antibodies were measured after second vaccinatio...
Autores principales: | Arumahandi de Silva, Amanthi Nadira, Frommert, Leonie Maria, Albach, Fredrik N, Klotsche, Jens, Scholz, Veronika, Jeworowski, Lara Maria, Schwarz, Tatjana, ten Hagen, Alexander, Zernicke, Jan, Corman, Victor Max, Drosten, Christian, Burmester, Gerd-Rüdiger, Biesen, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120396/ https://www.ncbi.nlm.nih.gov/pubmed/35288376 http://dx.doi.org/10.1136/annrheumdis-2021-221876 |
Ejemplares similares
-
Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccination
por: Habermann, Elisa, et al.
Publicado: (2022) -
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease
por: Frommert, Leonie Maria, et al.
Publicado: (2022) -
Improvement of humoral immunity by repeated dose-intensified COVID-19 vaccinations in primary non- to low-responders and B cell deficient rheumatic disease patients
por: ten Hagen, Alexander, et al.
Publicado: (2023) -
Performance of commercial SARS-CoV-2 wild-type and Omicron BA.1 antibody assays compared with pseudovirus neutralization tests
por: Habermann, E., et al.
Publicado: (2023) -
Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series
por: ten Hagen, Alexander, et al.
Publicado: (2022)